ArticleBritish journal of clinical pharmacology2023

Physiology-based pharmacokinetic modelling and experimental data suggest that rifabutin alters dolutegravir kinetics by both P-glycoprotein induction and concurrent inhibition.

Dirk Theile et al.PubMed ↗Publisher ↗

No numbers read from the abstract.